ReShape LifesciencesRSLS 
$4.47-0.67%24h
-0.67%24h
Global rank21029
Market cap$82.79M
Change 7d-7.61%
YTD Performance1659.84%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of ReShape Lifesciences (RSLS)
As of December 2024, ReShape Lifesciences has a market cap of $82.79M. This makes ReShape Lifesciences the world's 21029th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of ReShape Lifesciences from 2016 to 2024
-
Value:-
Market cap history of ReShape Lifesciences from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $3.05M | -34.08% |
| 2023 | $4.63M | -96.29% |
| 2022 | $124.83M | -91.78% |
| 2021 | $1.52B | -63.56% |
| 2020 | $4.17B | -21.05% |
| 2019 | $5.28B | -90.82% |
| 2018 | $57.51B | -68.68% |
| 2017 | $183.64B | -25.31% |
| 2016 | $245.87B | - |
RSLS Market Cap Today is $82.79M -0.67% - 20 Dec 2024
View largest stocks by market cap 
